Rosetrees Researchers’ News

Rosetrees Researchers’ News

Yoram Reshef

Advancing knowledge of Alzheimer’s disease, towards novel therapies

Dr. Laura Aitken, a senior postdoctoral research fellow with Professor Frank Gunn-Moore’s group, is currently leading a Rosetrees-funded project that aims to identify novel drugs for Alzheimer’s disease, at the University of St Andrews. In this project Laura has been...

Investigating molecular targets for auditory system regeneration

Professor Matthew Holley has received Rosetrees Trust funding to support a project that involved investigating molecular targets for auditory system regeneration, at Sheffield University. Dr. Tanaya Bardhan also worked on this project, as part of her PhD. They were...

Novel ways to identify HPV-driven head and neck cancers

Professor Ahmad Waseem is a Rosetrees Trust-funded researcher investigating the role of the Human Papilloma Viruses (HPVs) in head and neck cancers (HNSCCs). His team are based at Queen Mary University of London (QMUL), in the Centre for Oral Immunobiology and...

Precision medicine for children with cancer

Professor Louis Chesler, Professor of Paediatric Cancer Biology at the ICR, and Consultant at The Royal Marsden, has led a study that has unlocked the potential of using genetic testing to determine which treatment may be the best option for a child with cancer. This...

Opportunities to treat retinal diseases

Dr. Xinhua Shu is a Rosetrees Trust-funded researcher who, with his team at Glasgow Caledonian University, is investigating new treatments for age-related macular degeneration (AMD). AMD is the commonest cause of registered blindness in the developed world, with a...

Towards the clinic for tendon regeneration and rupture repair

Dr. Aram Saeed and Dr. Graham Riley are Rosetrees Trust-funded researchers, based at the University of East Anglia, who are leading a project on investigating the development of a 3D printed implantable device for tendon regeneration and rupture repair. Dr. Eleanor...

New urine marker in IgA Nephropathy

Dr. Athanasios Didangelos is a Rosetrees Trust-funded principal investigator at the University of Leicester, working in the Mayer IgA Nephropathy Laboratory led by Professor Jon Barratt. Their new publication in the Journal of Autoimmunity has identified a new urine...

New therapy to resolve inflammation and prevent tissue fibrosis

Recent Rosetrees Trust-funded research published in Nature Communications has highlighted the therapeutic potential of IFN-β in chronic and non-resolving inflammation, as well as fibrotic disorders and wound repair. Specifically, IFN-β has been identified as a...

Bone plugs offer new hope for treating cartilage damage

Professor Chaozong Liu is leading a Rosetrees Trust-funded project, with postdoctoral research associate Dr. Maryam Tamaddon, to investigate a tissue engineering approach for the treatment of cartilage damage, as a result of repetitive injuries or osteoarthritis....

Novel therapeutic approach to treat Parkinson’s disease?

Dr. Williams-Gray is a Rosetrees Trust-funded researcher based at the University of Cambridge, who is leading a team that is currently investigating the role of Toll-like receptors in brain inflammation and disease progression in Parkinson’s disease and its associated...

Bioengineering and saving babies’ lives

Dr. Tina Chowdhury is a Rosetrees Trust-funded researcher, leading a team of scientists in the field of regenerative medicine. She is based at the Institute of Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, where she also...

New Antibiotics on the horizon?

Antimicrobial resistance is recognised as the one of the gravest threats to global human health and is expected to kill more people than cancer by 2050. Therefore, new antibiotics are crucial. Rosetrees-funded research led by Dr. Ishwar Singh at Lincoln University has...

Next Generation Children’s Project

A Cambridge-led study, also known as the Next Generation Children’s Project, used progressive whole genome sequencing technology to help doctors identify and treat genetic conditions in babies and young children. The study, led by Professors Lucy Raymond and David...

New Grant Application and Management Process

We're pleased to announce that we are using Fluent Technology's Flexigrant software for all new applications and post-grant management. We're currently accepting applications for small and large project grants. Please download and read the guidelines for the scheme...

New Genetic ‘Barcode’ Testing Could Improve Bowel Cancer Diagnosis

A team lead by scientists at the Institute of Cancer Research have developed a new test based on genetic barcoding technology that can differentiate between the five distinct types of bowel cancer. This test, which sequences 38 genes, takes only a few hours to give a...

Active lifestyles may help nerves to heal after spinal injuries

An international team, led by researchers at Imperial College London have shown that leading an active lifestyle may increase the likelihood of damaged nerves regenerating after a spinal cord injury. The study was carried out in a rodent model and found that providing...

Pioneering new treatment for Parkinson’s disease

Results from a pioneering clinical trials programme that delivered an experimental treatment directly to the brain offer hope that it may be possible to restore the cells damaged in Parkinson’s. The multimillion-pound study, was funded by Parkinson’s UK with support...

Leukaemia promotes premature ageing in healthy bone marrow cells

Leukaemia promotes premature ageing in healthy bone marrow cells Research funded by the Rosetrees Trust and Norfolk’s Big C Charity has shown that leukaemic cancer cells drive the aging process in healthy bone marrow cells that surround them. The research was led by...